Tus kws kho mob
QP28-20 Updated Service Type Options for Surgery on Availity Portal
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 25, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1591 - 1600 ntawm 4179
Tus kws kho mob
QP29-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Peanut Allergy
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 25, 2020
Tus kws kho mob
QP30-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 25, 2020
Tus kws kho mob
QP31-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 25, 2020
Tus kws kho mob
2020 March Provider Press
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP8-20 Medical Drug Update for New to Market Golodirsen (Vyondys 53)
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 08, 2020
Tus kws kho mob
QP25-20 Pharmacy Benefit Exclusion for Injectafer®, Feraheme®, Venofer®, INFeD®, Ferrlecit®, and generic Ferrlecit®
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 11, 2020
Tus kws kho mob
QP26-20 CMS Decision Memo on Acupuncture for Chronic Low Back Pain
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 11, 2020
Tus kws kho mob
QP24-20 Pharmacy Benefit Update – Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 11, 2020
Tus kws kho mob
QP8R1-20 Update: Medical Drug Update for Golodirsen (Vyondys 53)
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 11, 2020